Cheryl Gault
Direttore operativo presso Rapport Therapeutics, Inc.
Patrimonio netto: 3 M $ in data 31/05/2024
Profilo
Cheryl Gault is currently the Chief Operating Officer at Rapport Therapeutics, Inc. She previously worked as the Head of Sales & Marketing at Genzyme Corp.
From 2017 to 2019, she served as the VP of Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. Cheryl also held the position of Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023.
She completed her undergraduate degree at Boston College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. 0.45% | 06/06/2024 | 157 941 ( 0.45% ) | 3 M $ | 31/05/2024 |
Posizioni attive di Cheryl Gault
| Società | Posizione | Inizio |
|---|---|---|
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Direttore operativo | 07/09/2023 |
Precedenti posizioni note di Cheryl Gault
| Società | Posizione | Fine |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Direttore operativo | 28/07/2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Vendite & Marketing | - |
Formazione di Cheryl Gault
| Boston College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
 | Health Technology |
| Aziende private | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Cheryl Gault
